Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Comparing Physostigmine vs Lorazepam for Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome

NCT03090620 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT03090620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03090620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Comparing Physostigmine vs Lorazepam for Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Completed
Start date
March 30, 2017
Completion date
August 31, 2020
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticholinergics toxicity